News Releases

Date	Title	Document
Date Jun 16, 2026	Title Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry	Document PDF
Date Jun 11, 2026	Title IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation	Document PDF
Date Jun 09, 2026	Title iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress	Document PDF
Date May 13, 2026	Title IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization	Document PDF
Date May 06, 2026	Title iMDx to Release First Quarter 2026 Results on May 13, 2026	Document PDF
Date Apr 14, 2026	Title Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay	Document PDF
Date Mar 26, 2026	Title IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results	Document PDF
Date Mar 20, 2026	Title iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference	Document PDF
Date Mar 13, 2026	Title Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score	Document PDF
Date Mar 03, 2026	Title Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission	Document PDF